Wolfe Research initiated coverage on Axalta Coating Systems
$AXTA
Paints/Coatings
Consumer Discretionary
Wolfe Research initiated coverage of Axalta Coating Systems with a rating of Peer Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/7/2025 | $40.00 | Neutral → Buy | UBS |
| 1/17/2025 | $41.00 | Peer Perform → Outperform | Wolfe Research |
| 12/18/2024 | $45.00 → $41.00 | Buy → Neutral | Citigroup |
| 12/17/2024 | Overweight → Sector Weight | KeyBanc Capital Markets | |
| 11/13/2024 | $47.00 | Outperform | Evercore ISI |
| 3/1/2024 | Peer Perform | Wolfe Research | |
| 1/8/2024 | $35.00 → $36.00 | Buy → Neutral | UBS |
| 6/14/2023 | $37.00 | Buy | Citigroup |
4 - Axalta Coating Systems Ltd. (0001616862) (Issuer)
4 - Axalta Coating Systems Ltd. (0001616862) (Issuer)
4 - Axalta Coating Systems Ltd. (0001616862) (Issuer)
PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (AXTA), a leading global coatings company, announced that it has won two 2025 Edison Awards™. Axalta Irus Scan™ won Silver in the Automotive Materials category and Axalta's MyColor won Bronze in the Automotive Materials category. This is the seventh consecutive year that Axalta has earned coveted Edison Awards which honor market-leading innovations of new products and services. "Innovation is core to what we do at Axalta, and we continuously invest to help our customers solve challenges across surface aesthetics, performance and productivity," said Dr. Robert Roop, Chief Technology Officer. "We are incredibly proud t
Expanded executive team to support operational excellence and commercialization of the CellFX nanosecond PFA Platform Pulse Biosciences, Inc. (NASDAQ:PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3, 2025. "I am excited to announce Jon as our next CFO, further building upon our momentum at Pulse Biosciences. His experience as a financial leader at both growth stage and scaled public diversified medtech companies will be extremely valuable in our efforts to advance our nanosecon
PHILADELPHIA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta"), a leading global coatings company, announced its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Highlights Record fourth quarter net sales of $1.3 billionNet income increased 85% year over year to $137 million, with net income margins of 10.5%, a year over year improvement of 480 basis pointsRecord fourth quarter Adjusted EBITDA of $275 millionAdjusted EBITDA margin improved 170 basis points year over yearDiluted EPS increased 91% to $0.63 and Adjusted Diluted EPS increased 30% to $0.60 Fiscal Year 2024 Highlights Record full year net
SC 13G - Axalta Coating Systems Ltd. (0001616862) (Subject)
SC 13G/A - Axalta Coating Systems Ltd. (0001616862) (Subject)
SC 13G/A - Axalta Coating Systems Ltd. (0001616862) (Subject)
PHILADELPHIA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta"), a leading global coatings company, announced its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Highlights Record fourth quarter net sales of $1.3 billionNet income increased 85% year over year to $137 million, with net income margins of 10.5%, a year over year improvement of 480 basis pointsRecord fourth quarter Adjusted EBITDA of $275 millionAdjusted EBITDA margin improved 170 basis points year over yearDiluted EPS increased 91% to $0.63 and Adjusted Diluted EPS increased 30% to $0.60 Fiscal Year 2024 Highlights Record full year net
PHILADELPHIA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE:AXTA), a leading global coatings company, will release its fourth-quarter and full-year 2024 financial results at 6 a.m. ET on Tuesday, February 4. The release and supporting materials will be posted to Axalta's Investor Relations site. In addition, the company will host a conference call at 8 a.m. ET on February 4. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company's financial performance for the periods. A live webcast of the conference call will be available here. A replay of the webcast will be posted shortly
PHILADELPHIA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta"), a leading global coatings company, announced its financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights: Record third quarter net sales of $1.32 billionNet income increased 40% year over year to $102 million; net income margin of 7.7%Record third quarter Adjusted EBITDA of $291 millionAdjusted EBITDA margin improved 220 basis points year over year to 22.1%Diluted EPS increased 39% year over year to $0.46 and Adjusted Diluted EPS increased 31% year over year to $0.59Repurchased $50 million of common shares Third Quarter 2024 Consolidated Financial R
Expanded executive team to support operational excellence and commercialization of the CellFX nanosecond PFA Platform Pulse Biosciences, Inc. (NASDAQ:PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3, 2025. "I am excited to announce Jon as our next CFO, further building upon our momentum at Pulse Biosciences. His experience as a financial leader at both growth stage and scaled public diversified medtech companies will be extremely valuable in our efforts to advance our nanosecon
PHILADELPHIA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta" or the "Company"), a leading global coatings company, today announced that Tim Bowes has been appointed President, Global Industrial Coatings, effective January 27, 2025. Mr. Bowes will succeed Shelley Bausch who will be stepping down from her role. Most recently, Mr. Bowes served as Axalta's Senior Vice President and Chief Transformation Officer. Prior to joining Axalta, he served as Senior Vice President and President of Electrification, Industrial, Aftermarket, Purchasing & Supply Chain for Meritor. Mr. Bowes has also served as Senior Vice President and President of the Casting business un
PHILADELPHIA, July 08, 2024 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA), a leading global coatings company, today announced that Chris Evans has been appointed Vice President, Global Strategy and Colleen Lubic has been appointed Vice President, Investor Relations. The appointments are effective immediately and further demonstrate Axalta's bench strength. Evans has served as Axalta's VP, Investor Relations since early 2022. Prior to joining the company, he led the Investor Relations function for Ecovyst and was Director of Investor Relations and Corporate Strategy for Chemours. He also covered the U.S. chemical industry for more than four years as a sell-side equity analyst
10-K - Axalta Coating Systems Ltd. (0001616862) (Filer)
SCHEDULE 13G - Axalta Coating Systems Ltd. (0001616862) (Subject)
144 - Axalta Coating Systems Ltd. (0001616862) (Subject)
UBS upgraded Axalta Coating Systems from Neutral to Buy and set a new price target of $40.00
Wolfe Research upgraded Axalta Coating Systems from Peer Perform to Outperform and set a new price target of $41.00
Citigroup downgraded Axalta Coating Systems from Buy to Neutral and set a new price target of $41.00 from $45.00 previously